argenxvsMerck & Company

ARGX and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ARGX

argenx SE

$942.04

Value $58.3B

-0.66%
ARGX's page

MRK

Merck & Company, Inc.

$132.81

Value $328B

-3.61%
MRK's page

argenx (ARGX) has a market value of $58.3B and Merck & Company (MRK) $328B. Over the last year, with dividends, ARGX moved +1.3% and MRK +52.7%. The P/E is 45.1 for ARGX and 133.9 for MRK. Dividend yield: ARGX none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ARGX$58.3B

    MRK$328B

    MRK is 5.6 times ARGX

  • Revenue, 12 months

    ARGX$4.2B

    MRK$67.4B

    MRK is 16 times ARGX

  • Net income, 12 months

    ARGX$1.3B

    MRK$2.5B

    MRK is 1.9 times ARGX

  • Operating margin

    ARGX25.4%

    MRK–

  • ROIC

    ARGX11.4%

    MRK3.9%

    7.5 points apart

  • P/E

    ARGX45.1

    MRK133.9

    MRK is 3.0 times ARGX

  • Dividend yield

    ARGX0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    ARGX+213.3%

    MRK+94.3%

    119.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ARGX+213.3%

MRK+94.3%

10020030020222023202420252026
Returns by period
PeriodARGXWith dividendsMRKWith dividends
1 year since November 17, 2025+1.3%Price +1.3%+52.7%Price +48.4%
3 years since November 17, 2023+92.2%+24.3% a yearPrice +92.2%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021+213.3%+25.7% a yearPrice +213.3%+94.3%+14.2% a yearPrice +66.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ARGXargenxMRKMerck & Company

Valuation

ARGXMRK
Valuation
Price$942.04$132.81
Market value$58.3B$328B
Enterprise value (EV)$54.8B$372B
P/E45.1133.9
P/E, 5-year median–14.8
P/B8.07.3
EV/EBIT52.078.2
Free cash flow yield1.2%4.5%

Results and growth

ARGXMRK
Results and growth
Revenue, 12 months$4.2B$67.4B
Net income, 12 months$1.3B$2.5B
Free cash flow, 12 months$679M$14.7B
Earnings per share, 12 months$19.57$0.98
Revenue growth, year on year89.9%1.3%
Revenue growth a year, past+151.5%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ARGXMRK
Margins and returns on capital
Gross margin89.1%71.8%
Operating margin25.4%–
Net margin31.1%3.6%
ROIC11.4%3.9%
ROE17.6%5.2%

Balance sheet

ARGXMRK
Balance sheet
Cash$3.5B$9.7B
Total debt$47M$53.8B
Net debt / EBITDA–5.7
Interest cover258.2×2.4×

Dividends and buybacks

ARGXMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ARGX or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, argenx or Merck & Company?

By market value, Merck & Company ($328B) is about 5.6 times argenx ($58.3B), at today's prices.

How did ARGX and MRK stock do over the last 5 years?

Since November 17, 2021, ARGX's price moved +213.3% and MRK's +66.8%. With dividends: ARGX +213.3% (+25.7% a year), MRK +94.3% (+14.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ARGX or MRK?

The dividend yield at today's price is none for argenx and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of ARGX and MRK?

At today's price, the P/E is 45.1 for ARGX and 133.9 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, argenx or Merck & Company?

Over the last twelve months, the net margin was 31.1% for argenx and 3.6% for Merck & Company, and the operating margin 25.4% and –. Revenue was $4.2B and $67.4B.

Which is the better investment, argenx or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.